Dr Jessica Lloyd is a Strategic Evidence Manager within the Evidence and Implementation Department at Cancer Research UK. She leads work on liquid biopsy-based innovations; horizon scanning, triangulating evidence and insight and identifying evidence gaps relating to their evaluation and implementation across the cancer care pathway and subsequent impact on the health system.
Dr Jessica Lloyd and Dr Sowmiya Moorthie, of Cancer Research UK, discuss multi-cancer tests, their potential use in screening, their challenges and uncertainties.
Related content and links
About this blog
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.